(BBVA) Banco Bilbao Vizcaya - Overview
Sector: Financial Services | Industry: Banks - Diversified | Exchange: MC (Spain) | Market Cap: 111.018m EUR | Total Return: 79.4% in 12m
Banking, Insurance, Investments, Management
Total Rating 57
Safety 68
Buy Signal 0.72
Banks - Diversified
Industry Rotation: +10.4
Industry Rotation: +10.4
Market Cap:
130B
Avg Turnover: 224M EUR
Avg Turnover: 224M EUR
ATR:
3.20%
Peers RS (IBD): 67.6
Peers RS (IBD): 67.6
Risk 5d forecast
Volatility29.4%
Rel. Tail Risk-1.67%
Reward TTM
Sharpe Ratio1.92
Alpha60.00
Character TTM
Beta0.381
Beta Downside0.602
Drawdowns 3y
Max DD21.53%
CAGR/Max DD2.52
EPS (Earnings per Share)
EPS CAGR: 16.09%
EPS Trend: 90.5%
EPS Trend: 90.5%
Last SUE: -0.52
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 13.22%
Rev. Trend: 52.8%
Rev. Trend: 52.8%
Last SUE: 0.02
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: BBVA Banco Bilbao Vizcaya
BBVA is a Spanish multinational financial services company. It operates across retail, wholesale, investment, and transaction banking. Diversified banks, like BBVA, offer a broad range of financial products and services to varied client segments.
The company also engages in insurance, asset management, capital markets, and digital banking. Digital banking is a growing segment within the financial sector, focusing on online and mobile platforms for banking services.
BBVA has a global presence, with operations in Spain, Mexico, Turkey, South America, Europe, the United States, and Asia. Consider researching BBVAs financial performance and market position further on ValueRay.
- Mexican economic growth boosts loan demand and net interest income
- Turkish lira volatility impacts earnings and capital ratios
- European Central Bank interest rate policy affects profitability
- Regulatory fines and compliance costs erode banks net income
- South American political instability creates economic uncertainty
Piotroski VR‑10 (Strict)
6.5
| Net Income: 10.51b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 12.62 > 1.0 |
| NWC/Revenue: -1.28k% < 20% (prev -854.9%; Δ -422.3% < -1%) |
| CFO/TA 0.13 > 3% & CFO 115.23b > Net Income 10.51b |
| Net Debt (-70.92b) to EBITDA (17.75b): -4.00 < 3 |
| Current Ratio: 0.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (6.03b) vs 12m ago -0.85% < -2% |
| Gross Margin: 83.85% > 18% (prev 0.67%; Δ 8.32k% > 0.5%) |
| Asset Turnover: 4.61% > 50% (prev 5.91%; Δ -1.30% > 0%) |
| Interest Coverage Ratio: 0.99 > 6 (EBITDA TTM 17.75b / Interest Expense TTM 16.45b) |
Altman Z''
-3.17
| A: -0.56 (Total Current Assets 152.76b - Total Current Liabilities 633.09b) / Total Assets 859.58b |
| B: 0.07 (Retained Earnings 56.86b / Total Assets 859.58b) |
| C: 0.02 (EBIT TTM 16.23b / Avg Total Assets 815.99b) |
| D: 0.14 (Book Value of Equity 114.21b / Total Liabilities 797.78b) |
| Altman-Z'' Score: -3.17 = D |
What is the price of BBVA shares?
As of April 15, 2026, the stock is trading at EUR 20.07 with a total of 11,019,392 shares traded.
Over the past week, the price has changed by +9.73%, over one month by +13.81%, over three months by -1.95% and over the past year by +79.40%.
Over the past week, the price has changed by +9.73%, over one month by +13.81%, over three months by -1.95% and over the past year by +79.40%.
Is BBVA a buy, sell or hold?
Banco Bilbao Vizcaya has no consensus analysts rating.
What are the forecasts/targets for the BBVA price?
| Analysts Target Price | - | - |
Banco Bilbao Vizcaya (BBVA) - Fundamental Data Overview
as of 12 April 2026
Market Cap USD = 130.17b (111.02b EUR * 1.1725 EUR.USD)P/E Trailing = 11.196
P/E Forward = 10.395
P/S = 3.5079
P/B = 1.9356
P/EG = 1.962
Revenue TTM = 37.61b EUR
EBIT TTM = 16.23b EUR
EBITDA TTM = 17.75b EUR
Long Term Debt = 81.84b EUR (from longTermDebt, last quarter)
Short Term Debt = 26.04b EUR (from shortTermDebt, two quarters ago)
Debt = 81.84b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -70.92b EUR (recalculated: Debt 81.84b - CCE 152.76b)
Enterprise Value = 40.10b EUR (111.02b + Debt 81.84b - CCE 152.76b)
Interest Coverage Ratio = 0.99 (Ebit TTM 16.23b / Interest Expense TTM 16.45b)
EV/FCF = 0.35x (Enterprise Value 40.10b / FCF TTM 113.99b)
FCF Yield = 284.2% (FCF TTM 113.99b / Enterprise Value 40.10b)
FCF Margin = 303.1% (FCF TTM 113.99b / Revenue TTM 37.61b)
Net Margin = 27.95% (Net Income TTM 10.51b / Revenue TTM 37.61b)
Gross Margin = 83.85% ((Revenue TTM 37.61b - Cost of Revenue TTM 6.07b) / Revenue TTM)
Gross Margin QoQ = 82.18% (prev 83.98%)
Tobins Q-Ratio = 0.05 (Enterprise Value 40.10b / Total Assets 859.58b)
Interest Expense / Debt = 9.93% (Interest Expense 8.12b / Debt 81.84b)
Taxrate = 32.26% (1.27b / 3.93b)
NOPAT = 10.99b (EBIT 16.23b * (1 - 32.26%))
Current Ratio = 0.24 (Total Current Assets 152.76b / Total Current Liabilities 633.09b)
Debt / Equity = 1.43 (Debt 81.84b / totalStockholderEquity, last quarter 57.36b)
Debt / EBITDA = -4.00 (Net Debt -70.92b / EBITDA 17.75b)
Debt / FCF = -0.62 (Net Debt -70.92b / FCF TTM 113.99b)
Total Stockholder Equity = 56.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.29% (Net Income 10.51b / Total Assets 859.58b)
RoE = 18.53% (Net Income TTM 10.51b / Total Stockholder Equity 56.73b)
RoCE = 11.71% (EBIT 16.23b / Capital Employed (Equity 56.73b + L.T.Debt 81.84b))
RoIC = 8.15% (NOPAT 10.99b / Invested Capital 134.94b)
WACC = 7.07% (E(111.02b)/V(192.86b) * Re(7.32%) + D(81.84b)/V(192.86b) * Rd(9.93%) * (1-Tc(0.32)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 1.64%
[DCF] Terminal Value 75.19% ; FCFF base≈70.37b ; Y1≈46.20b ; Y5≈21.13b
[DCF] Fair Price = 102.4 (EV 505.78b - Net Debt -70.92b = Equity 576.70b / Shares 5.63b; r=7.07% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 90.49 | EPS CAGR: 16.09% | SUE: -0.52 | # QB: 0
Revenue Correlation: 52.84 | Revenue CAGR: 13.22% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.53 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.00 | Chg7d=+0.005 | Chg30d=+0.002 | Revisions Net=-2 | Growth EPS=+13.7% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=2.22 | Chg7d=+0.022 | Chg30d=+0.018 | Revisions Net=-2 | Growth EPS=+11.0% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.0% (Discount Rate 7.9% - Earnings Yield 8.9%)
[Growth] Growth Spread = +18.7% (Analyst 17.7% - Implied -1.0%)